Mechanisms influencing the immunodominance of T cell determinants by unknown
MECHANISMS INFLUENCING THE IMMUNODOMINANCE
OF T CELL DETERMINANTS
BY LUCIANO ADORINI,* ETTORE APPELLA,1 GINO DORIA,§
AND ZOLTAN A. NAGY*
From *Preclinical Research, Sandoz Ltd., CH-4002, Basel, Switzerland; the $Laboratory of
Cell Biology, National Cancer Institute, Bethesda, Maryland 20892; and the §Laboratory of
Pathology; ENEA, Centro Ricerche Energia, Casaccia 00100 Roma, Italy
T cells recognize foreign antigens usually as peptides associatedwith self-molecules
encoded bytheMHC (reviewed in reference 1). Thus, the bindingofimmunogenic
peptides to MHC molecules is a prerequisite for T cell activation (2). As demon-
stratedfor a classI molecule, each MHC glycoprotein appearsto have a single binding
site for peptides (3). Because the number of antigenic peptides to be presented to
T cells is very large, each MHC molecule must have the ability to bind many pep-
tides ofunrelated sequences, forexample, several ofthose generated bythe processing
ofa single protein antigen(4, 5). It would therefore be expected that T cells respond
toseveraldifferentepitopes on a single foreign protein. However, thisis not thecase:
T cell responses are generally specific for a few, and often only one, ofthe peptides
derived by processing of a protein antigen. These T cell epitopes are referred to
as immunodominant. Immunodominance ofselected T cell epitopes has indeed been
demonstrated for several proteins including cytochrome c(6), lysozyme (7, 8), myo-
globin (9), ovalbumin (10), influenzavirus hemagglutinin (11), staphylococcal nuclease
(12), ragweed allergen (13), bacteriophageX repressor (14), and acetylcholine receptor
(15). Furthermore, epitope immunodominance has been observed not only in class
II MHC-restricted T cell responses, but also in class I-restricted cytotoxic T cell
responses (16).
The molecular events involved in antigen processing are still poorly understood,
but the emerging view indicates that protein antigens undergo a limited degree of
proteolysis in an acidic intracytoplasmic compartment, the resulting peptides as-
sociatewith MHC molecules and are transported to the cell surface complexed with
these molocules(17). Accordingly, several mechanisms canbe anticipated to influence
T cell responsiveness to antigenic determinants; (a) availability of a given peptide
after antigen processing, (b) its ability to bind to MHC molecules, (c) competition
between differentpeptides derived fromthe same protein antigen (orotherproteins)
forbindingto MHC molecules, (d)presence ofTcells inthe repertoire ableto recog-
nizethe peptide-MHC complex, and (e) preferential activation ofhelper rather than
suppressor T cells by a given peptide. The results presented here provide evidence
for four of these five mechanisms operating during the T cell response to hen egg-
white lysozyme (HEL).'
' Abbreviation used in this paper: HEL, hen egg-white lysozyme.
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Materials and Methods
Mice.
￿
C3H and B10.A(4R) mice of either sex were obtained from Olac Ltd. (Bicester,
UK) and used when 2-3 mo old.
Antigens.
￿
HEL three times recrystallized was obtained from Sigma Chemical Co. (St. Louis,
MO). Peptides were synthetized by the Merrifield technique (18) and purified by reverse-
phase high-pressure liquid chromatography.
T Cell Proliferation.
￿
Mice were immunized subcutaneously at the tail base and into the
hind footpads with 3.5-7 nmol antigen (HEL or peptides) emulsified in CFA containing H37Ra
mycobacteria (Difco Laboratories, Detroit, MI). Eight days after immunization, lymph nodes
draining the injection site were removed and 5 x 105 cells were cultured in wells of micro-
titer plates (Costar, Cambridge, MA) in RPMI 1640 medium (Gibco Laboratories, Basel,
CH) supplemented with 2 MM L-glutamine, 50 AM 2-ME, 50 ug/ml gentamicin (Sigma
Chemical Co.), and 2.5% pooled human AB serum with the indicated antigen concentra-
tions. Cultures were set up in triplicates from pooled lymph node cells oftwo mice per group.
Cultures were incubated for 3 d in a humidified atmosphere of 5% C02 in air and were
pulsed 10 h before harvesting with 1 pCi [3H]TdR (40 Ci/mmol; The Radiochemical Center,
Amersham, UK). Incorporation of [3H]TdR was measured by liquid scintillation spectrom-
etry. The MHC class II molecule involved in peptide 1-18 recognition by T cells was deter-
mined by inhibition of cell proliferation with anti-la mAbs. Ascitic fluid from hybridoma
11-5.2 (anti-I-Ak) or culture supernatant from hybridoma Y17 (anti-I-Eb.k,,,,,") were added
to cultures in the presence of antigen at a final dilution of 1:200 or 1:2, respectively.
T Cell Hybridomas.
￿
T cell hybridomas were established by polyethylene glycol-induced
fusion of lymph node cells with the thymoma line BW5147. Lymph node cells were obtained
from mice immunized with HEL-CFA and restimulated in vitro with 7 AM HEL for 3 d
before cell fusion. After fusion, cells were cultured in selective medium and growing hybrids
were screened for IL-2 production in response to HEL and syngeneic APC. Cultures con-
taining 5 x 104 T hybridoma cells and 2 .5 x 104 LK 35.2 (H-2k/d) cells (obtained from the
American Type Culture Collection, Rockville, MD) were set up, without antigen or with
7 AM HEL, in 0.2 ml of culture medium. After 24 h ofculture, 50-u1 aliquots of supernatant
were transferred to microculture wells containing 104 CTLL cells and, after an additional
24 h of incubation, the presence of IL-2 was assessed by [3H]TdR incorporation during the
last 4 h ofculture. Positive hybridomas were then screened on a panel of synthetic HEL pep-
tides. Hybridomas reactive to a HEL peptide were cloned by limiting dilution and individual
clones were retested for IL-2 production. The Ia molecule involved in antigen recognition
by individual T cell hybridomas was determined by comparing the IL-2 production obtained
in the presence of irradiated (2,400 rad) spleen cells from C3H (expressing I-A' and I-Ek
molecules) and B10.A(4R) (expressing only I-A' molecules) mice.
Competitionfor Antigen Presentation.
￿
Competition for antigen presentation was performed
on fixed LK 35.2 cells. Cells were fixedby resuspending them in 0.025% glutaraldehyde (Fluka,
Buchs, Switzerland), and after 30 s the reaction was stopped by addition of 0.2 M glycine.
Fixed LK 35.2 cells (5 x 104/well) were incubated with the indicated concentration of com-
petitor (1-200 AM) and with a suboptimal concentration (0.5-1 AM) of antigenic peptide
for 18 h at 37°C. The cells were then washed three times and 5 x 104 T hybridoma cells
were added. After 24 h, 50-ul aliquots of culture supernatant were transferred to microcul-
ture wells and IL-2 production was quantitated as described before. The degree ofcompeti-
tion for antigen presentation was determined by the regression line obtained by plotting per-
cent inhibition ofantigen presentation against the concentration ofthe inhibitory peptide used.
Results
Responsiveness ofMice Expressing I-A' and I-Ek Molecules to HEL Peptides.
￿
C3H mice
expressing both I-A' and I-E' molecules and B10 .A(4R) mice expressing only I-A'
molecules (19) were immunized with HEL, and their lymph node cellswere restimu-
lated in vitro with a panel of 17 synthetic peptides encompassing the entire HEL
sequence (Fig. 1). T cell proliferation was observed in both strains to peptides 46-61,ADORINI ET AL.
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FIGURE 1 .
￿
Synthetic HEL peptides used in the present study. The HEL amino acid sequence
is shownby thesingle letter code. In peptides 107-129, 110-129, and 112-129 the cysteine at posi-
tion 127 has been substituted with alanine to prevent formation of a disulfide bridge with the
cysteine at position 115.
51-66, 107-129, 110-129, and 112-129 (Fig. 2). In addition, cells from C3H mice
responded to peptide 1-18. Thus, at least three immunodominant T cell epitopes
could be identified by using these peptides. Since T cell proliferative responses are
restricted by class II MHC molecules (20, 21), the finding that both C311 and
B10.A(4R) mice respond to sequences 51-61 and 112-129 indicates that these pep-
tides are recognized in associationwith the class II molecule shared by these strains,
that is, I-A'. In contrast, the Tcell determinant included in the sequence 1-18 is
recognized in association with I-E' molecules, since it restimulated HEL-primed
T cells from C3H mice, but not those from B10.A(4R) mice. All the other peptides
tested failed to restimulate HEL-primed T cells.
Interaction ofHEL Peptides with I-A' and I-E* Molecules.
￿
To investigate the interac-
tion of HEL peptides with class II molecules, we determined the ability of these
peptides to compete for presentation with antigenic peptides to T cell hybridomas.
Previous work has demonstrated that the competition of peptides for antigen pre-
sentation correlates well with their capability to bind to purified la molecules (4,
22). Inthe competition assays we used glutaraldehyde-fixedLK 35.2 cells (expressing
both I-Ak and I-Ek molecules) as APC, and two pairs of T cell hybridomas, re-
stricted by either I-Ak or I-Ek, each specific for a different HEL peptide (Table I).
Three ofthese hybridomas recognize immunodominant peptides (we have isolated
several independent hybrids with these specificities), whereas the peptide-MHC
specificity expressed by hybridoma 2H6.4 is rather rare in our hybridoma collec-
tion. Competition was assessed as a decrease in IL-2 production by T cell hybrid-
omasin response to antigen andAPC. A typical experiment is shown in Fig. 3 where
the response ofhybridoma 2C8.4 to peptide 110-129 was used as a read-out system
to evaluate the capacity ofall nonstimulatory HEL peptides to inhibit antigen pre-2094
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FIGURE 2.
￿
I-Ak- and I-Ek-restricted T cell-dependent proliferative response oflymph node cells
to HEL peptides. CM and B10.A(4R) mice were immunized subcutaneously into the hind footpads
and at the tail base with 7 nmol/mouse HEL in CFA and 8 d later draining lymph node cells
were cultured with different concentrations of the indicated synthetic HEL peptides. Data are
presented as mean [3H]TdR incorporation and standard deviation of triplicate cultures with back-
ground values (medium alone) subtracted (A cpm).
sentation. Strong competition is exertedby peptides 46-61, 51-61, and 51-66, inter-
mediate competition by peptides 25-43, 31-43, and 74-86, and weak competition
by peptides 101-116 and 105-120. The otherpeptides did not exhibit discernible com-
petition in the concentration range used (up to 200 gM). The compilation of data
from four to six experiments for each of the four hybridomas is presented in Table
II. A very good correlation was found between the competition values obtained for
each pair of hybridomas restricted by either I-Ak or I-Ek, irrespective of their pep-
tide specificity. Based on theseresults, several HEL peptides appear to interact with
I-A' (using the shortest sequences of overlapping peptides in the set examined):
TABLE I
T Cell Hybridomas Used in the Present Study
Peptide specificity refers to the shortest HEL peptide tested.
Strain of
origin Immunization Denomination
la restriction
molecule
Peptide
specificity'
C3H HEL 2C8.4 I-Ak 112-129
C3H HEL 3E11 .1 I-Ak 51-61
C3H HEL 2H6.4 I-Ek 105-120
C3H HEL 1B8.1 I-Ek 1-18R
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FIGURE 3.
￿
Competition of the response of hy-
bridoma 2C8.4 to peptide 110-129 by HEL pep-
tides. Inhibition ofantigen presentation was de-
termined by incubating glutaraldehyde-fixed LK
35.2 cells(5 x 104cells/well) with 1 pM peptide
110-129 and 1.5-200 PM ofnonstimulatory HEL
peptides for 18h. Thecells were then washed and
2C8.4 hybridoma cells (5 x 104 cells/well) were
added. After24 h, antigen-specific IL-2 produc-
tion wasdetermined by adding 50-p1 aliquots of
culture supernatant to 104 CTLL cells foran ad-
ditional 24 h. Data are presented as percent of
the [3H]TdRincorporation obtained in response
to 1 pM of peptide 110-129. Responses in the
presence or absence of peptide 110-129 were
57,963 and 722 cpm, respectively.
51-61, 112-129, 31-43, 74-86, 101-116, and 105-120. Thus, at least five nonoverlap-
ping sequences among the HEL peptides tested are able to interact with the I-Ak
molecule.
In terms of competition for I-Ek molecules, 1-18 was found to be the most efficient
peptide. This was expected, because the I-Ek-restricted component of anti-HEL re-
sponse was also directed againstthis sequence (see in Fig. 2). TheTcell determinant
appears to map in the NH2-terminal region of sequence 1-18, since the interaction
of peptide 8-29 with I-Ek molecules is weaker than that of 1-18; furthermore, no
response can be observed to peptide8-29 after HELpriming, andhybridoma 1138.1
also fails to recognize peptide 8-29. In addition to 1-18, the following peptides were
found to interact, rather weakly, with the I-Ek molecule: 25-43 (but not 31-43),
51-66 and, as for the I-Ak molecule, all the COOH-terminal HEL peptides tested
in the region 101-129 (Table II).
Immunogenicity ofNonimmunodominantHEL Peptides.
￿
So farthe results have demon-
strated that several of the HEL peptides, although capable of binding to class II
molecules, cannot restimulate a response of HEL-primed T cells. We therefore de-
termined the immunogenicity of these peptides by injecting them into C3H and
B10.A(4R) mice. Thecontrol experiment in Fig. 4 confirms that thedominant pep-
tide 1-18 is, as predicted (see Fig. 2), co-recognized only with I-Ek molecules, since
it induces a proliferative T cell response in C3H butnot in B10.A(4R) mice. Formal
evidence forthe restriction by I-El molecules of the T cell response to peptide 1-18
wasobtained by theinhibition ofcell proliferation by anti-IamAbs (datanotshown).
An interesting situation is represented by the nondominant peptide (25-43) that
binds to both I-Ak and I-Ek molecules, but is much stronger immunogenic in C3H2096
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FIGURE 4.
￿
T cell-dependent proliferative response of lymph node cells from peptide-primed
mice to the immunizing peptide and to HEL. C3H and B10.A(4R) mice were immunized as
in Fig. 2 with 7 nmol/mouse of the indicated HEL peptide in CFA and 8 d later the draining
lymph node cells were cultured with different concentrations of the immunizing peptide (O) or
HEL ("). Data are presented as in Fig. 2.2098
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than in B10.A(4R) mice. This finding indicates that peptide 25-43 is recognized
by T cells preferentially in association with I-E' molecules, probably due to a low
precursor frequency of I-A'-restricted clones specific for this peptide. The T cells
induced by peptides 1-18 and 25-43 can be restimulated with HEL, which indicates
that the antigenic determinants in these peptides become available upon processing
of HEL. Conversely, the priming with peptide 94-110 induced T cells responding
to the peptide but not to HEL, which indicates that this peptide is not generated
(or destroyed) during processing. The same applies to T cells induced by peptide
74-86, that is, they can be restimulated with the peptide but not with HEL (Fig.
5) . As expected, the immunodominant peptide 1-18 induces a higher peptide-
dependent proliferative response than the nondominant peptides 25-43 and 94-110.
In conclusion, two of thethree nonimmunodominant peptides tested are not gener-
ated during processing, and therefore, cannot induce T cells upon priming with
HEL. However, the third nondominant peptide (peptide 25-43) is available after
processing, and thus, thenonresponsiveness to this peptide after primingwith HEL
must arise by a different mechanism.
In Vivo Competition between HEL Pe;6tidesforInteraction with Class IIMolecules.
￿
Since
all HEL peptides tested were found to be immunogenic irrespective of whether they
were immunodominant or not, we have examined thepossibility that in vivo compe-
tition between differentpeptides forpresentation by class II molecules may account
for immunodominance. Previous studies have demonstrated that competition be-
tween self and non-self peptides for binding to class II molecules can occur in vivo
(23). To test the in vivo competition for I-A' molecules, we immunized B10.A(4R)
mice with peptides 51-66, 74-86, 110-129, or with an equimolar amount of peptides
51-66 and 74-86 or 51-66 and 110-129. The results in Fig. 5 demonstrate that a
vigorous antipeptide response is induced when each peptide is injected separately
into mice. However, when the immunodominant peptide 51-66 is injected together
with an equimolar dose of peptide 74-86, the proliferative T cell response to the
latter is drastically reduced, whereas the response to 51-66 is affected only margi-
nally. In contrast, injectionof thetwo immunodominant peptides 51-66 and 110-129
together does not result in an appreciable competition in vivo. Surprisingly the re-
sponse to 51-66 is even increased. Thus, immunodominant peptides can effectively
compete with a nondominant one for induction of a response in vivo. It should be
pointed out, however, that thenondominant peptide 74-86tested in this experiment
is not available afterprocessing (Fig. 5, and reference 24), and therefore, the latter
fact rather than competition is the cause fornonresponsiveness to this peptide after
priming with HEL.
To investigate whethercompetitionbetween HEL peptides in vivo is a physiologi-
cally relevant process, we chose a situation in which two peptides, one im-
munodominant and theothernot, were both available afterprocessing of HEL. Pep-
tides 1-18 and 25-43 exemplify this situation since both interact with I-E' molecules,
both induce a T cell response to themselves and to HEL, but only 1-18 is im-
munodominant. We therefore injected these peptides either separately or mixed in
equimolar ratio into C3H mice. The results in Fig. 6 confirm that both peptides
are able to induce antipeptide T cell responses when injected separately. However,
when peptides 1-18 and 25-43 areinjected together amarked decrease in the prolifer-
ative T cell response to peptide 25-43 is observed, whereas the response to peptideb
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FIGURE 5.
￿
In vivo competition between HEL peptides for interaction with I-Ak molecules.
B10.A(4R) mice were immunized as in Fig. 2 with 3.5 nmol/mouse peptide 51-66 (O), 74-86
(A), or 110-129 (p). In addition, mice were immunized in the same inoculum with 3.5 nmol
peptide 51-66 and 3.5 nmol peptide 74-86 (A) or with 3.5 nmol peptide 51-66 and 3.5 nmol
peptide 110-129 (/). 8 dlater draining lymph node cells were cultured with different concentra-
tions of the indicated antigen. Data are expressed as in Fig. 2.
2099
1-18 remains unaffected. These results indicate that competition, in vivo, between
different peptides derived from agiven protein antigen represents aphysiologically
relevant mechanism underlying T cell epitope immunodominance.2100
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￿
In vivo competition betweenHELpeptides forinteraction with I-Ek molecules. C3H
mice were immunized as in Fig. 2 with 7 nmollmouse peptide 1-18 (O), peptide 25-43 (A) or
with a mixture of 7 nmol of peptide 1-18 and 7 nmol of peptide 25-43 (0). 8 d later draining
lymphnode cells were cultured with differentconcentrations of the indicatedpeptides. Data are
expressed as in Fig. 2.
Discussion
A peptide derived from a protein molecule is considered immunodominant when
it restimulates a proliferative response ofTcells primed with thewhole protein (25).
To determine the mechanisms underlying immunodominance, we have analyzed
the proliferative T cell response elicited by a panel of synthetic HEL peptides in
lymph node cells from HEL-primed mice. Three immunodominant T cell epitopes
have been identified, in HEL sequences 1-18, 51-61, and 112-129. Epitopes 51-61
and 112-129 are recognized by T cells in association with I-A' molecules, whereas
the epitope in HEL sequence 1-18 is recognized in association with I-Ek molecules.
The epitope in sequence 51-61 had also been identified by Allen et al. (26). Several
other HEL peptides are not immunodominant, although they are capable of inter-
acting with I-Ak or I-E' molecules or with both. At least two of them, 74-86 and
94-110, are not available after processing ofHEL. Hence, immunization with HEL
does not induce responses against these peptides, and conversely, T cells induced
by these peptides do not react to HEL.
Most interesting is the case ofpeptide 25-43. This peptide is not dominant, al-
though it induces a response that can be recalled by HEL, which indicates that the
epitope is available after antigen processing. The reason for the lack ofdominance
is twofold. First, the peptide, although it binds to I-Ak slightly better than to I-Ek
molecules, induces only a marginal I-Ak-restricted response. A similar case has re-ADORINI ET AL.
￿
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cently been noted by Guillet et al. (27). This failure could result from a low fre-
quency of the relevant clones in the T cell repertoire or the T cells induced may
have a poor capacity to proliferate. Second, the precursor of I-E'-restricted T cells
specific for peptide 25-43 are not activated because of in vivo competition by the
response to the dominant peptide 1-18. Since peptide 1-18 binds to I-El molecules
better than peptide 25-43, the former is likely to inhibit binding of thelatter to the
presenting molecule. The two mechanisms together render the response to peptide
25-43 cryptic in H-2k Mice.
The results also demonstrate that the simultaneous presence of two im-
munodominant T cell epitopes, such as those in peptides 51-66 and 110-129 both
interacting with I-Ak molecules, does not result in competition when peptides are
injected together at equimolar concentrations. Similarly, no competition was ob-
served when the mouse lysozyme peptide 46-62 was injected together with peptide
112-129 in B10.A(4R) mice, whereas acleardose-dependent competitionwasachieved
by increasing the amount of mouse lysozyme peptide 46-62 injected (23). Such a
coexistence is anticipated between peptides that bind with relatively high affinity
to the presenting molecule, and thus, have both the chance to occupy a number of
binding sites sufficient for T cell activation. However, we have observed an addi-
tional unexpected synergism betweenthesepeptides, in that the presence ofpeptide
110-129 enhanced significantly and reproducibly the response to peptide 51-66. An
explanation for this synergy is that these peptides may be further processed (28)
and, as a result, both may fit into a single MHC binding site or they may form
crossreactive epitopes upon binding to MHC molecules. The possibility of further
processing is supported by our observation that the two peptides compete, instead
of synergizing, when tested on fixed APC incapable of processing. However, the al-
ternative possibility that these two peptides influence each other in solution before
binding to the presenting molecules, also remains open.
The degree of "foreigness" to the mouse immune system does not exert a major
influence in determiningimmunodominance since, for example, theimmunodominant
HEL sequence 51-61 has only one amino acid substitution as compared with the
corresponding mousesequence (29), whereas the nonimmunodominant peptide25-43
has seven.
It has been suggested that amphipathicity is an important feature of im-
munodominant Tcell epitopes (30), butother studies (31) argue that the helix formed
need not be amphipathic. Among the immunodominant T cell epitopes we have
studied, the sequences 51-61 and 1-18 exhibit amphipathicity but 112-129 does not,
indicating that this property is not essential for immunodominance.
The immunodominance ofa given T cell epitope may also depend on its capacity
to induce preferentially helper or suppressor T cells. Although this mechanism has
not been addressed in the present work, it appears to operate, under certain condi-
tions, in the anti-HEL immune response (32).
In conclusion, the phenomenon of epitope dominance appears to be the outcome
ofacomplexinterplaybetween physical-chemicalrulesgoverningpeptide-MHC in-
teractions andaseries ofbiological mechanisms. The present work hasdemonstrated
four distinct mechanisms operating in thedetermination of dominant epitopes, but
leaves the possibility that further ones exist open.2102
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Summary
The preferential recognition of certain amino acid sequences from foreign pro-
tein antigens by T cells is referred to as T cell epitope immunodominance. To deter-
mine the mechanisms underlying this phenomenon, we have studied the correlation
between the interaction of a series of synthetic peptides encompassing the entire
hen egg-white lysozyme (HEL) sequence. with class II molecules of the H-2k haplo-
type, and T cell responsiveness to these peptides. After HEL priming, three im-
munodominant T cell epitopes were found: two, included in the HEL sequences
51-61 and 112-129, were recognized in association with I-A' molecules, and one,
included in sequence 1-18, in association with I-E' molecules. Accordingly, these
peptides bound to the appropriate class II molecule, as demonstrated by competi-
tion for antigen presentation. Several other HEL peptides, although capable of as-
sociating with class 11 molecules, were not immunodominant. The absence of im-
munodominance has been shown to arise by three different mechanisms: (a)
competition by an immunodominant peptide for presentation in vivo, (b) failure
to generate the peptide during antigen processing, and (c) an inherently poor ca-
pacity of the T cell repertoire to respond to a particular peptide-MHC complex.
Receivedforpublication 8 August 1988.
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